Key facts
- It has raised $580K; the latest was Early Stage VC ($90K) in Nov 2025.
- Notable investors include Plug and Play Tech Center, Andreessen Horowitz, Boost VC, Tehnopol Startup Incubator, Triin Hertmann — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Elnora Ai
- ·The full record, as it builds
Funding rounds
No funding rounds for Elnora Ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elnora Ai
Developer of an AI-driven platform designed to improve biomedical laboratory protocols by learning from both successful and failed experiments. The company offers systems that capture and utilize negative experimental data and integrate with existing lab workflows such as cell culture, iPSC differentiation, and organoid development, enabling biotechnology companies, pharmaceutical organizations, and contract research firms to optimize protocols, reduce experimental waste, and accelerate movement from research to clinical application.
- Sector
- Healthcare
- HQ
- Salt Lake City, UT, United States
- Founded
- 2024
- Employees
- 2
- Website
- elnora.ai/
- Ownership
- Privately Held (backing)
Elnora Ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elnora Ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elnora Ai in its N-PORT filings yet. We sweep new filings monthly.